References
1. Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA,
Campbell RL, et al. Anaphylaxis-a 2020 practice parameter update,
systematic review, and Grading of Recommendations, Assessment,
Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol.
2020;145:1082-123.
2. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF, Jr., Bock SA,
Branum A, et al. Second symposium on the definition and management of
anaphylaxis: summary report–Second National Institute of Allergy and
Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J
Allergy Clin Immunol. 2006;117:391-7.
3. El Turki A, Smith H, Llewellyn C, Jones CJ. A systematic review of
patients’, parents’ and healthcare professionals’ adrenaline
auto-injector administration techniques. EMJ. 2017;34:403-16.
4. Saleh-Langenberg J, de Vries S, Bak E, Kollen BJ, Flokstra-de Blok
BMJ, Dubois AEJ. Incomplete and incorrect epinephrine auto-injector
training to food-allergic patients by pharmacists in the Netherlands.
Pediatr Allergy Immunol. 2017;28:238-44.
5. Dumeier HK, Richter LA, Neininger MP, Prenzel F, Kiess W, Bertsche A,
et al. Knowledge of allergies and performance in epinephrine
auto-injector use: a controlled intervention in preschool
teachers. Eur J Pediatr . 2018;177:575-81.
6. Robinson MN, Dharmage SC, Tang ML. Comparison of adrenaline
auto-injector devices: ease of use and ability to recall use. Pediatr
Allergy Immunol. 2014;25:462-7.
7. Portnoy J, Wade RL, Kessler C. Patient carrying time, confidence, and
training with epinephrine autoinjectors: The RACE Survey. J Allergy Clin
Immunol Pract. 2019;7:2252-61.